PortfoliosLab logoPortfoliosLab logo
EGLN.L vs. NVO
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

EGLN.L vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in iShares Physical Gold ETC (EGLN.L) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

EGLN.L is traded in EUR, while NVO is traded in USD. To make them comparable, the NVO values have been converted to EUR using the latest available exchange rates.

Returns By Period

In the year-to-date period, EGLN.L achieves a 2.32% return, which is significantly higher than NVO's -15.02% return. Over the past 10 years, EGLN.L has outperformed NVO with an annualized return of 11.21%, while NVO has yielded a comparatively lower 5.93% annualized return.


EGLN.L

1D
-0.30%
1M
-6.16%
YTD
2.32%
6M
3.98%
1Y
28.23%
3Y*
27.04%
5Y*
19.18%
10Y*
11.21%

NVO

1D
-4.63%
1M
-9.02%
YTD
-15.02%
6M
-8.41%
1Y
-43.17%
3Y*
-19.44%
5Y*
2.89%
10Y*
5.93%
*Multi-year figures are annualized to reflect compound growth (CAGR)

EGLN.L vs. NVO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
EGLN.L
iShares Physical Gold ETC
2.32%46.01%34.32%9.37%6.00%3.85%13.68%20.59%3.38%-0.47%
NVO
Novo Nordisk A/S
-15.02%-46.43%-10.38%50.20%30.26%75.75%13.17%31.61%-8.89%34.13%

Correlation

The correlation between EGLN.L and NVO is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.12

Correlation (3Y)
Calculated over the trailing 3-year period

0.07

Correlation (5Y)
Calculated over the trailing 5-year period

0.04

Correlation (10Y)
Calculated over the trailing 10-year period

0.05

Correlation (All Time)
Calculated using the full available price history since Apr 8, 2011

0.01

The correlation between EGLN.L and NVO shifts across timeframes, from 0.01 (all time) to 0.12 (1 year), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

EGLN.L vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EGLN.L
EGLN.L Risk / Return Rank: 3636
Overall Rank
EGLN.L Sharpe Ratio Rank: 3838
Sharpe Ratio Rank
EGLN.L Sortino Ratio Rank: 3333
Sortino Ratio Rank
EGLN.L Omega Ratio Rank: 4242
Omega Ratio Rank
EGLN.L Calmar Ratio Rank: 3636
Calmar Ratio Rank
EGLN.L Martin Ratio Rank: 3131
Martin Ratio Rank

NVO
NVO Risk / Return Rank: 1212
Overall Rank
NVO Sharpe Ratio Rank: 99
Sharpe Ratio Rank
NVO Sortino Ratio Rank: 1212
Sortino Ratio Rank
NVO Omega Ratio Rank: 1010
Omega Ratio Rank
NVO Calmar Ratio Rank: 1313
Calmar Ratio Rank
NVO Martin Ratio Rank: 1717
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

EGLN.L vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Physical Gold ETC (EGLN.L) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


EGLN.LNVODifference
Sharpe ratioReturn per unit of total volatility

+2.06

Sortino ratioReturn per unit of downside risk

+2.70

Omega ratioGain probability vs. loss probability

1.24

0.85

+0.40

Calmar ratioReturn relative to maximum drawdown

1.63

-0.79

+2.42

Martin ratioReturn relative to average drawdown

4.17

-1.15

+5.32

EGLN.L vs. NVO - Sharpe Ratio Comparison

The current EGLN.L Sharpe Ratio is 1.21, which is higher than the NVO Sharpe Ratio of -0.85. The chart below compares the historical Sharpe Ratios of EGLN.L and NVO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


EGLN.LNVODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.21

-0.85

+2.06

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

1.12

0.08

+1.04

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.70

0.18

+0.52

Sharpe Ratio (All Time)

Calculated using the full available price history

0.37

0.47

-0.10

Drawdowns

EGLN.L vs. NVO - Drawdown Comparison

The maximum EGLN.L drawdown since its inception was -47.44%, smaller than the maximum NVO drawdown of -76.45%. Use the drawdown chart below to compare losses from any high point for EGLN.L and NVO.


Loading charts...

Drawdown Indicators


EGLN.LNVODifference

Max Drawdown

Largest peak-to-trough decline

-47.44%

-76.45%

+29.01%

Max Drawdown (1Y)

Largest decline over 1 year

-17.24%

-54.72%

+37.48%

Max Drawdown (3Y)

Largest decline over 3 years

-17.24%

-76.45%

+59.21%

Max Drawdown (5Y)

Largest decline over 5 years

-17.24%

-76.45%

+59.21%

Max Drawdown (10Y)

Largest decline over 10 years

-26.21%

-76.45%

+50.24%

Current Drawdown

Current decline from peak

-17.24%

-72.31%

+55.07%

Average Drawdown

Average peak-to-trough decline

-22.54%

-13.76%

-8.78%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.75%

37.61%

-30.86%

Volatility

EGLN.L vs. NVO - Volatility Comparison

The current volatility for iShares Physical Gold ETC (EGLN.L) is 5.12%, while Novo Nordisk A/S (NVO) has a volatility of 9.49%. This indicates that EGLN.L experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


EGLN.LNVODifference

Volatility (1M)

Calculated over the trailing 1-month period

5.12%

9.49%

-4.37%

Volatility (6M)

Calculated over the trailing 6-month period

20.24%

37.62%

-17.38%

Volatility (1Y)

Calculated over the trailing 1-year period

23.28%

51.08%

-27.80%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

17.14%

38.00%

-20.86%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

15.94%

32.48%

-16.54%

Dividends

EGLN.L vs. NVO - Dividend Comparison

EGLN.L has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 4.39%.


PositionTTM20252024202320222021202020192018201720162015
EGLN.L
iShares Physical Gold ETC
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NVO
Novo Nordisk A/S
4.39%3.31%1.68%1.00%1.20%1.35%1.87%2.14%1.45%1.52%2.87%0.92%

Frequently Asked Questions


EGLN.L and NVO have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for EGLN.L and NVO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer